TMEM184C anticorps (C-Term)

N° du produit ABIN1887070

Détail du produit anti-TMEM184C anticorps

Antigène: TMEM184C (Transmembrane Protein 184C (TMEM184C))

Épitope: C-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TMEM184C est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Purification: Affinity chromatography purified via peptide column

Immunogène: 15 amino acid peptide near the carboxy terminus of human TMEM184C.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.

Conseil sur la manipulation: Avoid freezing and thawing repeatly.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term use.Store at -20 °C for long term preservation.

Détails sur TMEM184C

Antigène: TMEM184C (Transmembrane Protein 184C (TMEM184C))

Autre désignation: TMEM184C (TMEM184C Produits)

Synonymes: anticorps TMEM34, anticorps 8430433H16Rik, anticorps AI645453, anticorps AL033298, anticorps BC004056, anticorps Tmem34, anticorps transmembrane protein 184C, anticorps transmembrane protein 184C L homeolog, anticorps TMEM184C, anticorps Tmem184c, anticorps tmem184c.L

Sujet: Anaplastic thyroid cancer is one of the most lethal forms of cancer, but the precise carcinogenic mechanism has not been identified.TMEM184C, also known as TMEM34, was identified in a cDNA microarray analysis as being down-regulated in anaplastic thyroid cancers compared to normal thyroid tissues.TMEM184C protein expression was also lower in cell lines derived from these types of cancers compared to that of normal thyroid tissues or cell lines based on other types of thyroid cancers.Furthermore, transfection of TMEM34 into KTA2 cells led to the inhibition of cell growth, suggesting that TMEM184C might act as a tumor suppressor in anaplastic thyroid cancers.
Synonyms: Transmembrane Protein 184C, TMEM34

NCBI Accession: NP_060711